Discover
MTVA
MetaVia Inc.
1.45
2 x 1.06
2 x 1.84
bid
ask
+
0.02
1.40%
2 @ 05:48 AM
1.47 +0.02 (1.10%)
| Ytd | -82.78% | |
| 1y | -79.72% |
1.42
day range
1.49
0.97
52 week range
19.03
| Open | 1.42 | Prev Close | 1.43 | Low | 1.42 | High | 1.49 | Mkt Cap | 7.49M |
| Vol | 65.65K | Avg Vol | 3.77M | EPS | -4.21 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.28 | Short Ratio | 0.65 | Inst. Own | 12.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.85 | 200-d Avg | 5.15 | 1yr Est | 17.33 |
MTVA News
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
Why Nuvalent Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
MetaVia Reports Up To 9.1% Weight Loss In Phase 1 DA-1726 Study, Showcases Combination Data For Meta
DA-1726 Phase 1, 48 mg Cohort Achieved Up to 9.1% Mean Body Weight Reduction at Day 54 Without Evide
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
Why Solidion Technology Shares Are Rallying Over 50%; Here Are 20 Stocks Moving Premarket
Solidion Technology, Inc. (NASDAQ: STI) rose 50.55% in pre-market trading on Friday after announcing
benzinga.com
MetaVia To Present Data On Obesity, Metabolic Therapies At Emerging Growth Conference
MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company focused on transforming cardiomet